临床实践指南中去强化治疗建议的研究：是加强还是减少？
An Examination of Deintensification Recommendations in Clinical Practice Guidelines: Stepping Up or Scaling Back?
机构信息
VA Center for Clinical Management and Research, Ann Arbor, Michigan.
University of Michigan Medical School, Ann Arbor, Michigan.
出版信息
JAMA Intern Med. 2018 Mar 1;178(3):414-416. doi: 10.1001/jamainternmed.2017.7198.
Abstract
In light of initiatives to decrease use of unnecessary services, this article examines whether current guidelines for diabetes and cardiovascular disease preferentially recommend intensification rather than deintensification of care.
摘要
鉴于减少不必要服务使用的举措，本文探讨了当前关于糖尿病和心血管疾病的指南是否优先推荐强化而非弱化治疗。
相似文献
1
An Examination of Deintensification Recommendations in Clinical Practice Guidelines: Stepping Up or Scaling Back?临床实践指南中去强化治疗建议的研究：是加强还是减少？
JAMA Intern Med. 2018 Mar 1;178(3):414-416. doi: 10.1001/jamainternmed.2017.7198.
2
Orthopaedic Healthcare Worldwide: Using Clinical Practice Guidelines in Clinical Decision Making.全球骨科医疗保健：在临床决策中使用临床实践指南。
Clin Orthop Relat Res. 2015 Sep;473(9):2762-4. doi: 10.1007/s11999-015-4336-4. Epub 2015 May 16.
3
Consensus and clinical practice guidelines in Latin America: Who, where, when and how.拉丁美洲的共识与临床实践指南：何人、何地、何时以及如何制定
Ann Hepatol. 2019 Mar-Apr;18(2):281-284. doi: 10.1016/j.aohep.2019.03.001. Epub 2019 Apr 15.
4
Physician adherence to clinical practice guidelines: does it really matter?医生对临床实践指南的遵循：这真的重要吗？
Am Heart J. 2003 Jan;145(1):13-5. doi: 10.1067/mhj.2003.25.
5
Changing Current Practice in Urology: Improving Guideline Development and Implementation Through Stakeholder Engagement.改变泌尿外科现状：通过利益相关者的参与来改进指南的制定和实施。
Eur Urol. 2017 Aug;72(2):161-163. doi: 10.1016/j.eururo.2017.02.008. Epub 2017 Feb 22.
6
Clinical inertia-Time to reappraise the terminology?临床惰性——是时候重新评估这个术语了吗？
Prim Care Diabetes. 2017 Apr;11(2):105-106. doi: 10.1016/j.pcd.2017.01.007. Epub 2017 Feb 20.
7
Is it time to change follow-up recommendations in colorectal cancer?是时候改变结直肠癌的随访建议了吗？
Clin Transl Oncol. 2020 Jan;22(1):163-164. doi: 10.1007/s12094-019-02117-8. Epub 2019 May 10.
8
Cardiovascular events, diabetes and guidelines: the virtue of simplicity.心血管事件、糖尿病与指南：简约的价值。
Cardiovasc Diabetol. 2019 Mar 28;18(1):42. doi: 10.1186/s12933-019-0844-y.
9
The 2013 ACC/AHA Cholesterol Management Guideline: Clearing the Confusion from Noncontroversial Components.2013年美国心脏病学会/美国心脏协会胆固醇管理指南：消除无争议部分的困惑
Tex Heart Inst J. 2016 Aug 1;43(4):313-4. doi: 10.14503/THIJ-16-5798. eCollection 2016 Aug.
10
Equity of access to kidney transplantation: to what extent should international guidelines differ?肾脏移植的获取公平性：国际指南应在多大程度上存在差异？
Transplantation. 2012 Oct 15;94(7):669-70. doi: 10.1097/TP.0b013e31826370ab.
引用本文的文献
1
BEYOND 2 years: durability of metabolic benefits by simplification of complex insulin regimens in type 2 diabetes.2 年以上：通过简化复杂的 2 型糖尿病胰岛素方案，实现代谢益处的持久性。
Endocrine. 2024 Feb;83(2):399-404. doi: 10.1007/s12020-023-03547-9. Epub 2023 Oct 3.
2
Focus and features of prescribing indications spanning multiple chronic conditions in older adults: A narrative review.老年人多种慢性病处方适应症的重点与特征：一项叙述性综述
J Multimorb Comorb. 2021 Apr 28;11:26335565211012876. doi: 10.1177/26335565211012876. eCollection 2021 Jan-Dec.
3
Expert Panel Guidance and Narrative Review of Treatment Simplification of Complex Insulin Regimens to Improve Outcomes in Type 2 Diabetes.专家小组关于简化复杂胰岛素治疗方案以改善2型糖尿病治疗效果的指南及叙述性综述
Diabetes Ther. 2022 Apr;13(4):619-634. doi: 10.1007/s13300-022-01222-2. Epub 2022 Mar 11.
4
[The problem of medical overuse : Finding a definition and solutions].[医疗过度使用问题：寻找定义与解决方案]
Internist (Berl). 2021 Apr;62(4):343-353. doi: 10.1007/s00108-021-00957-7. Epub 2021 Feb 13.
5
Potential diabetes overtreatment and risk of adverse events among older adults in Ontario: a population-based study.安大略省老年人潜在的糖尿病过度治疗与不良事件风险：一项基于人群的研究。
Diabetologia. 2021 May;64(5):1093-1102. doi: 10.1007/s00125-020-05370-7. Epub 2021 Jan 25.
6
GP's perspectives on laboratory test use for monitoring long-term conditions: an audit of current testing practice.全科医生对用于监测长期疾病的实验室检测的看法：当前检测实践的审计。
BMC Fam Pract. 2020 Dec 5;21(1):257. doi: 10.1186/s12875-020-01331-6.
7
Rates, determinants and success of implementing deprescribing in people with type 2 diabetes: A scoping review.在 2 型糖尿病患者中实施药物减量的比率、决定因素和成功率：范围综述。
Diabet Med. 2021 Feb;38(2):e14408. doi: 10.1111/dme.14408. Epub 2020 Oct 2.
8
Low-Value Care and Clinician Engagement in a Large Medicare Shared Savings Program ACO: a Survey of Frontline Clinicians.大型医疗保险共享节约计划 accountable care organization（ACO）中的低价值医疗与临床医生参与情况：一线临床医生调查
J Gen Intern Med. 2020 Jan;35(1):133-141. doi: 10.1007/s11606-019-05511-8. Epub 2019 Nov 8.
9
Approaches to Risk Assessment Among Older Patients With Diabetes.老年糖尿病患者的风险评估方法。
Curr Diab Rep. 2019 Jul 19;19(8):59. doi: 10.1007/s11892-019-1172-z.
10
Clinical practice guidelines for older people with multimorbidity and life-limiting illness: what are the implications for deprescribing?患有多种慢性病和危及生命疾病的老年人的临床实践指南：减药有哪些影响？
Ther Adv Drug Saf. 2018 Sep 12;9(11):619-630. doi: 10.1177/2042098618795770. eCollection 2018 Nov.
本文引用的文献
1
Inclusion of Hypoglycemia in Clinical Practice Guidelines and Performance Measures in the Care of Patients With Diabetes.糖尿病患者护理临床实践指南和绩效指标中纳入低血糖相关内容。
JAMA Intern Med. 2016 Nov 1;176(11):1714-1716. doi: 10.1001/jamainternmed.2016.5046.
2
Deintensification of Routine Medical Services: The Next Frontier for Improving Care Quality.常规医疗服务的去强化：提升医疗质量的新前沿
JAMA Intern Med. 2016 Jul 1;176(7):978-80. doi: 10.1001/jamainternmed.2016.2292.
3
Undermeasuring Overuse--An Examination of National Clinical Performance Measures.测量不足与过度使用——对国家临床绩效指标的审视
JAMA Intern Med. 2015 Oct;175(10):1709-11. doi: 10.1001/jamainternmed.2015.4025.
4
Choosing wisely--the politics and economics of labeling low-value services.明智选择——低价值服务的标签化的政治和经济。
N Engl J Med. 2014 Feb 13;370(7):589-92. doi: 10.1056/NEJMp1314965. Epub 2014 Jan 22.
5
Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification.将临床试验的总结结果应用于个体患者的局限性：风险分层的必要性。
JAMA. 2007 Sep 12;298(10):1209-12. doi: 10.1001/jama.298.10.1209.
Zotero 插件